Evaluation of a new measure of blood glucose variability in diabetes

Diabetes Care

Volumn 29, Issue 11, 2006, Pages 2433-2438

  Kovatchev, Boris P ^a   Otto, Erik ^b   Cox, Daniel ^a   Gonder Frederick, Linda ^a   Clarke, William ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b LifeScan Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SELF MONITORING;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EVALUATION STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33845484053     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1085     Document Type: Article

References (29)

1. Aaby Svendsen P, Lauritzen T, Soegard U, Nerup J: Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia 23:403-405, 1982
2. Santiago JV: Lessons from the Diabetes Control and Complications Trial. Diabetes 42:1549-1554, 1993
3. UK Prospective Diabetes Study Group (UKPDS): Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
4. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
5. The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271-286, 1997
6. Henderson JN, Allen KV, Deary IJ, Frier BM: Hypoglycemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 20:1016-1021, 2003
7. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 26:1902-1912, 2003
8. Cryer PE: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45:937-948, 2002
9. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke WL: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21:1870-1875, 1998
10. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke WL: Methods for quantifying self-monitoring blood glucose profiles exemplified by an examination of blood glucose patterns in patients with type 1 and type 2 diabetes. Diabetes Technol Ther 4:295-303, 2002
11. Kovatchev BP, Cox DJ, Kumar A, Gonder-Frederick LA, Clarke WL: Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose (SMBG) data. Diabetes Technol Ther 5:817-828, 2003
12. American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting hypoglycemia in diabetes. Diabetes Care 28:1245-1249, 2005
13. American Diabetes Association: Postprandial blood glucose: consensus statement. Diabetes Care 24:775-778, 2001
14. Basu A, Alzaid A, Dinneen S, Caumo A, Cobelli C, Rizza R: Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest 97:2351-2361, 1996
15. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
16. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583, 1996
17. Hanefeld M: Post-prandial hyperglycaemia and vascular disease. Int J Clin Pract Suppl 13-18, 2000
18. Hanefeld M, Temelkova-Kurktschiev T: The postprandial state and the risk of atherosclerosis. Diabet Med 14 (Suppl. 3):S6-S11, 1997
19. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E: The role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 25:1439-1443, 2002
20. Ceriello A: New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26:1589-1596, 2003
21. Quagliaro L, Piconi L, Assalone R, Martinelli L, Motz E, Ceriello A: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795-2804, 2003
22. Esposito K, Giugliano D, Nappo F, Martella K, the Campanian Postprandial Hyperglycemia Study Group: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214-219, 2004
23. Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942, 1999
24. 1c level. Diabetes Care 23:1830-1834, 2000
25. Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 19:178-181, 2005
26. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke WL: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care 20:1655-1658, 1997
27. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of blood glucose control in diabetics. Acta Med Scand 177:95-102, 1965
28. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AMJ, Vantyghem MC: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation Diabetes 53:955-962, 2004
29. Service FJ, Molner GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability Diabetes 19:644-655, 1970